PGHH FY26 PAT Rises 19% on Flat Sales

A virtual investors and analysts call was held on Tuesday, June 16, 2026, from 1:30 P.M. to 2:49 P.M. (IST).

Mr. V. Kumar, Managing Director
Ms. Srividya Srinivasan, Incoming Chief Financial Officer (effective July 1, 2026)
Ms. Zeal Rupani, Moderator (Corporate Secretarial team)

Sales: ₹4300 crore, flat versus the same period last year.
Profit After Tax (PAT): ₹850 crore, up 19% versus the comparable period last year.
The results were delivered through targeted savings programs, which enabled reinvestment into the business.

Mr. Kumar outlined a dynamic operating environment characterized by:

1. Media Fragmentation: Challenging to capture consumer attention.

2. Inflation: Impacting consumer spending across food, energy, and healthcare, making 'affordability' an evolving concept.

3. Evolving Retail Landscape: Transformative shifts in the path to purchase, including quick commerce, social commerce, and agentic AI.

The company's response is its Integrated Growth Strategy, which consists of five elements:

A portfolio of daily-use products in categories where performance matters.
Superiority across product, package, brand communication, retail execution, and value.
Productivity to fund superiority and deliver financial results.
Constructive disruption to stay ahead.
An organization that is engaged, enabled, and excited to serve consumers.

The category is described as high-involvement and high-engagement.
Whisper Period Panties: A focus area, designed for 360-degree leakage protection. Sold 10 crore units in the last fiscal year. The business tripled in the fiscal year.
Whisper Nights Portfolio: Upgraded to address leakage concerns at night due to gravity. The portfolio is growing ahead of the sanitary napkins category, and half of all pad users choose it. It is the most distributed nights brand in India.
Marketing & Communication: Featured a campaign with cricketer Jemimah Rodrigues and a 360-degree plan using gynecologists and relatable voices for education.

The company is a leader in Rubs, Cough Drops, Inhaler, and Cold Tablets segments.
Vicks Cough Syrup: Recently launched with a non-drowsy formula for wet and dry cough.
Vicks ZzzQuil Natura Sleep Gummies: Upgraded to combine 5 mg of melatonin with 50 mg of ashwagandha. Packaging was also upgraded to be moisture-proof.
Vicks VapoRub: Communication focused on delivering "All-Night relief for un-interrupted sleep," leading to double-digit growth and share gains within 6 months.
Vicks Cough Drops: Featured innovative cultural integrations, including a concert and a stand-up comedy show. The revamped product with 2X actives led to double-digit offtake growth and volume share gains.

The company delivered ₹86 crores of savings via targeted productivity and savings programs in the last year.
Each business unit has multi-year savings master plans to drive efficiency across the value chain.

The company highlighted investments in data platforms and an AI Factory to drive operational efficiency.
Initiatives include:
Smart Assortment: Drove double-digit portfolio optimization.
AI-led automated availability checks: To ensure product availability.

Over the past 10 years, the company has delivered consistent mid-single-digit sales growth and a compounded annual profit growth of 8%.
Return on equity has tripled, and net profit margin has increased by approximately 200 basis points.
Absolute sales and profit have both approximately doubled over the past 10 years.
The company has a record 30 years of consistent dividend payout and has delivered cumulative returns of over ₹3000 per share to shareholders over the past decade.

The Indian economy is estimated to grow at 6.5% for the year, within the 10-year trend.
The FMCG industry faces evolving trends: non-food inflation is below RBI's 4% target, rural consumption is higher than urban but softening, and the West Asia crisis is being monitored.
Feminine Hygiene category is growing at 7-10%.
Healthcare sub-categories are growing at about 2-3%, with volatility noted due to monsoon patterns.

Key questions from analysts and institutional investors were addressed:

Industry Growth & Market Share: Whisper is the market leader in Feminine Care; Vicks is a leader in its healthcare segments.
Innovation in Feminine Hygiene: The company defended its innovation record, citing Whisper Period Panties as a key new segment where it is the undisputed leader.
Competition: Strategy remains focused on being consumer-first and winning with superiority across all vectors.
Revenue Growth Slowdown (Last 3-5 Years): Attributed to evolving consumer needs, increased competition (over 50 new entrants in feminine care in 10 years), and a dynamic media/retail landscape.
Period Panties Performance: Highlighted as a successful sub-segment, with one in four Qcomm period product buyers choosing panties, and Whisper being the #1 choice.
Operating Margins: Improved structural margins by 1 point this year through premium innovation and cost savings.
Management Tenure: Changes in CEO/CFO roles were addressed, noting that the core strategy remains constant and is executed by leaders who often move to global/regional roles within P&G.
Cost Pressures & Inflation: Acknowledged volatility from the West Asia conflict, with crude and resin prices up 30-50%. The company's supply chain is mitigating risks to avoid stock-outs.
Questions regarding future investments, manufacturing footprint, and share buybacks were declined to avoid sharing unpublished price-sensitive information.

P&G Shiksha, the flagship CSR program, celebrated impacting over 1 crore children from underserved communities.
The program focuses on erasing learning gaps, aligned with the National Education Policy.
An anthem, 'Ab Sab Jayenge School', was launched in partnership with JioHotstar.

The call included forward-looking statements subject to risks and uncertainties, as detailed in the disclaimer read at the beginning.